FDA OKs Cell Therapy to Lower Infection Risk After Stem Cell Transplant
Por um escritor misterioso
Descrição
Omidubicel reduced infections in blood cancer patients from 60% to 39% at 100 days posttransplant
What are the differences between platelet rich plasma and stem
Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again
2014 Payers' Guide to New FDA Approvals by Dalia Buffery - Issuu
Stem Cell Transplantation, Autologous Stem Cell Transplantation
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer
Cells, Free Full-Text
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed
NCCN Adds Tafasitamab-cxix in Combination with Lenalidomide to B
PDF) Human amniotic mesenchymal stem cells to promote/suppress
de
por adulto (o preço varia de acordo com o tamanho do grupo)